Top Markets
Coin of the day
W World Corp. W World Corp.

W World Corp.

WWHC
Clasificación en acciones #22981
W World Corp. is a biopharmaceutical firm dedicated to identifying and... W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primary experimental drugs: Levotofisopam, currently in clinical trials as a non-sedative therapy for Gout, and Dextofisopam, a non-serotonergic compound that has successfully concluded Phase IIa and Phase IIb clinical trials for irritable bowel syndrome (IBS). Established in 1990, W World Corp. maintains its corporate headquarters in North Las Vegas, Nevada.
Precio por acción
$0.8
Última sincronización: 2024-01-02
Capitalización bursátil
$80.24M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio W World Corp. (WWHC)
Historial de rendimiento por dividendo de W World Corp. (WWHC)
Rendimiento por dividendo (TTM) de W World Corp. (símbolo bursátil: WWHC) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de W World Corp. (WWHC) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras